PREVENTION OF CARDIAC DISEASE BY SUBCUTANEOUS DEFEROXAMINE IN PATIENTS WITH THALASSEMIA MAJOR

被引：255
|
作者：
WOLFE, L
OLIVIERI, N
SALLAN, D
COLAN, S
ROSE, V
PROPPER, R
FREEDMAN, MH
NATHAN, DG
机构：
[1] CHILDRENS HOSP MED CTR, DIV HEMATOL ONCOL, BOSTON, MA 02115 USA
[2] DANA FARBER CANC INST, BOSTON, MA USA
[3] HOSP SICK CHILDREN, DIV HEMATOL, TORONTO M5G 1X8, ONTARIO, CANADA
[4] HOSP SICK CHILDREN, DEPT CARDIOL, TORONTO M5G 1X8, ONTARIO, CANADA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 1985年 / 312卷 / 25期
关键词：
D O I：
10.1056/NEJM198506203122503
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1600 / 1603
页数：4
相关论文
共 50 条
  • [31] DEFEROXAMINE-INDUCED GROWTH-RETARDATION IN PATIENTS WITH THALASSEMIA MAJOR
    DEVIRGILIIS, S
    CONGIA, M
    FRAU, F
    ARGIOLU, F
    DIANA, G
    CUCCA, F
    VARSI, A
    SANNA, G
    PODDA, G
    FODDE, M
    PIRASTU, GF
    CAO, A
    JOURNAL OF PEDIATRICS, 1988, 113 (04): : 661 - 669
  • [32] THALASSEMIA MAJOR - CHELATION-THERAPY WITH DEFEROXAMINE
    DEMIANI, MSA
    DEHERRLEIN, MES
    PENALVER, JA
    MEDICINA-BUENOS AIRES, 1985, 45 (03) : 231 - 234
  • [33] RENAL ABNORMALITIES IN PATIENTS WITH BETA-THALASSEMIA MAJOR (BETA-TM) TREATED WITH CHRONIC SUBCUTANEOUS (SQ) DEFEROXAMINE (DF)
    WAYNE, AS
    ROSENBLUM, ND
    SALLAN, D
    RINK, LM
    DAVIES, KJ
    PEARSON, HA
    BLOOD, 1993, 82 (10) : A476 - A476
  • [34] Deferiprone versus deferoxamine in patients with thalassemia major: a randomized clinical trial - Reply
    Maggio, A
    D'Amico, G
    Morabito, A
    BLOOD CELLS MOLECULES AND DISEASES, 2004, 32 (01) : 141 - 142
  • [35] Efficacy of High Dose and Short Course of Deferoxamine Infusion on Cardiac Remodeling Of Children with Thalassemia Major
    Shahryari, Mehdi
    Mehdizadegan, Nima
    Amoozgar, Hamid
    Borzouee, Mohammad
    Ajami, Gholamhossein
    Cheriki, Sirous
    Edraki, Mohammad Reza
    Shakiba, Ali Mohammad
    Mohammadi, Hamid
    Keshavarz, Kambiz
    IRANIAN JOURNAL OF PEDIATRICS, 2019, 29 (02)
  • [36] Evaluation of cardiac functions in patients with thalassemia major
    Küçük, NÖ
    Aras, G
    Sipahi, T
    Ibis, E
    Akar, N
    Soylu, A
    Erbay, G
    ANNALS OF NUCLEAR MEDICINE, 1999, 13 (03) : 175 - 179
  • [37] Hypothyroidis and Cardiac Complications In Thalassemia Major Patients
    Rita Gamberini, Maria
    Meloni, Antonella
    Rossi, Giuseppe
    Secchi, Giuseppina
    D'Ambrosio, Alfonso
    Macchi, Silvia
    Pulini, Stefano
    De Franceschi, Lucia
    Vallone, Antonino
    Lombardi, Massimo
    Pepe, Alessia
    BLOOD, 2013, 122 (21)
  • [38] Evaluation of cardiac functions in patients with thalassemia major
    Küçük N.Ö.
    Aras G.
    Sipahi T.
    Ibiş E.
    Akar N.
    Soylu A.
    Erbay G.
    Annals of Nuclear Medicine, 1999, 13 (3) : 175 - 179
  • [39] MANAGEMENT OF CARDIAC COMPLICATIONS IN PATIENTS WITH THALASSEMIA MAJOR
    VECCHIO, C
    DERCHI, G
    SEMINARS IN HEMATOLOGY, 1995, 32 (04) : 288 - 296
  • [40] Deferasirox Compared With Deferoxamine For The Removal Of Cardiac Iron In Patients With β-Thalassemia Major: 2-Year Data From The Cordelia Extension
    Pennell, Dudley J.
    Porter, John B.
    Piga, Antonio
    Lai, Yongrong
    El-Beshlawy, Amal
    Belhoul, Khawla
    Elalfy, Mohsen
    Yesilipek, Akif
    Kilinc, Yurdanur
    Wegener, Antje
    Habr, Dany
    Shen, Junwu
    Aydinok, Yesim
    BLOOD, 2013, 122 (21)
12345